In case of involvement of the facial nerve, the dilemma that the surgeon is faced with is that of whether to preserve the nerve at the cost of leaving behind a small remnant of tumor or achieve total eradication by sacrificing the nerve. The decision to leave behind tumor in an attempt to save the nerve can be justified if the following 2 factors can be proved: 1) that the incidence and the rate of tumor regrowth is acceptably low, and 2) that there is a significant benefit in terms of postoperative preservation of facial nerve function. In an attempt to rationalize this decision-making process we evaluated the behavior of all residual tumors, in terms of regrowth and facial nerve function, after incomplete excisions of VSs.
Methods
This was a retrospective study of patients surgically treated for VS between January 1987 and December 2010 at the Gruppo Otologico, Piacenza-Rome, Italy, a quaternary referral center for otology and skull base surgery. The case records of all patients who underwent surgical treatment of VSs were analyzed. All patients in whom an incomplete excision was performed were analyzed. Excisions of VSs were defined as in Table 1 . Tumors in the NTR (near-total resection) and STR (subtotal resection) categories were followed up with a wait-and-rescan approach, whereas the tumors in the PR (partial resection) category were subjected to a second-stage surgery. The clinical features, investigations, surgical procedure, indications for incomplete excision, sites of residual tumor, and postoperative follow-up of the patients included in the series were noted and analyzed.
After surgery, all patients included in the study underwent follow-up at the outpatient clinic and baseline MRI at the 3rd and 12th postoperative months and subsequently every year for 7-10 years postoperatively or as indicated clinically. Preoperative and postoperative facial nerve function was noted and was classified according to the House-Brackmann (HB) grading of facial nerve function. The preoperative tumor size and postoperative residual tumor size were evaluated using MRI (1.5 T) by measuring their diameters in 2 perpendicular directions (in mm). Growth of the residual tumor was determined by the increase in its greatest dimension on follow-up MRI studies.
Results
A total of 2368 patients underwent surgery for VS between 1987 and 2010 at the Gruppo Otologico. Of these, 88 patients underwent a retrosigmoid approach and 90 underwent a middle cranial fossa approach for small tumors, and total excision was achieved in all cases. Of the remaining 2190 patients who underwent an extended translabyrinthine approach, 155 patients (7.1%) had incomplete excisions (Fig. 1) . Patients in the PR category were excluded from this series. Patients with neurofibromatosis, those with a history of radiotherapy or radiosurgery, those in whom the facial nerve was sacrificed during surgery, and those with less than 1 year of follow-up were also excluded. Therefore, 111 patients who had undergone incomplete excisions of their VS were included in the study. The male/ female ratio was 41:70. Patient age ranged from 25 to 82 years (mean 62 years). The follow-up period ranged from 12 to 156 months (mean 45.4 months); 42 (38%) of our patients were followed up for more than 5 years. On KaplanMeier analysis (Fig. 2) , the 5-year tumor regrowth-free survival was 92%, with a mean tumor regrowth-free period of 140 months (95% CI 127-151 months).
Near-Total Versus Subtotal Resection
Of the 111 patients, 73 (65.77%) underwent an NTR, while the remaining 38 (34.23%) underwent an STR. The tumor sizes undergoing NTR ranged from 10 to 50 mm (mean 29 mm), while those treated with STR ranged from 20 to 50 mm (mean 32.2 mm).
Cystic Versus Solid Tumors
Of the 111 tumors, 62 (55.86%) were cystic VSs and the remaining 49 (44.14%) were solid VSs ( 
Sites of Residual Tumors
Of the 111 patients who underwent incomplete tumor excision, the residual tumor was left behind on the facial nerve alone in 62 patients (55.86%), on the facial nerve and vessels in 2 patients (1.80%), on the facial nerve and brainstem in 15 patients (13.51%), on the brainstem alone in 25 patients (22.52%), on the brainstem and vessels in 4 patients (3.60%), and on a vessel alone in 3 patients (2.70%) (Table 3) .
Overall, the facial nerve was involved in 51 (69. 
Facial Nerve Status
Facial nerve status was evaluated immediately postoperatively and during follow-up. Of the 111 patients, 6 patients had preoperative facial nerve paralysis and were excluded from analysis. In the remaining 105 cases with normal preoperative facial nerve function, anatomical integrity of the facial nerve was preserved in all cases. Postoperative facial nerve function was HB Grades I and II in 51 patients (48.57%), HB Grade III in 34 patients (32.38%), and HB Grades IV-VI in 20 patients (19.05%).
Postoperatively at 1 year (Tables 4 and 5 ), 33 patients in the NTR group (49.25%) had good facial nerve function (HB Grades I and II), 24 (35.82%) had intermediate facial nerve function (HB Grade III), and 10 (14.93%) had poor facial nerve function (HB Grades IV-VI). In the STR group, 18 patients (47.37%) had good facial nerve function (HB Grades I and II), 10 (26.32%) had intermediate facial nerve function (HB Grade III), and 10 patients (26.32%) had poor facial nerve function (HB Grades IV-VI). There was no significant difference in good, intermediate, and unsatisfactory facial nerve function between the groups (chi-square test, p > 0.05). Of the 6 patients with preoperative facial nerve paralysis, 3 had HB Grade VI paralysis after undergoing previous surgery at other centers and presented with large residual tumors, which were treated with revision surgery at our center. One patient had preoperative HB Grade III function, and 2 patients had preoperative HB Grade II facial nerve function. There was no deterioration in facial nerve function in any of our patients during long-term follow-up. More than 50% of patients with tumors smaller than 3 cm had good facial nerve function after they underwent NTR or STR, while about 30% patients with tumor size larger than 3 cm had good facial nerve function.
Details of Patients With Tumor Regrowth and Management
Seven patients (6.3%) showed evidence of tumor regrowth on follow-up with MRI (Table 6 ). All 7 patients who showed evidence of tumor regrowth were in the STR group. No patient in the NTR group exhibited regrowth. The incidence of regrowth in the STR group was 7 (18.4%) of 38. Six (30%) of the 20 patients with solid VSs and 1 (5.56%) of the 18 patients with cystic VSs exhibited regrowth. The difference was not statistically significant (Fisher exact test, p > 0.05). Of the 7 patients, 1 had a minimal and slow increase in size on follow-up but with no clinical impact and hence underwent a wait-and-rescan followup. Six other patients showed sizable and rapid regrowth of the residual tumors and needed further treatment. Three of the patients underwent a second surgery with total excision in 1 case and near-total excision in 2 cases, and 3 other patients were treated with stereotactic radiosurgery (SRS).
Discussion
Considering that VSs are benign slow-growing tumors, partial removal can be used as a strategy to reduce postoperative morbidity, and therefore it is important to know the behavior of the residual tumor in incomplete resections. While some authors believe that small fragments of residual tumor are effectively devitalized and do not grow, 23, 28, 33 others have proved that the proliferative activity of the tumor itself, as measured by monoclonal antibody MIB-1, may contribute to regrowth. 1, 5, 20 The factors that need to be addressed are the pattern of regrowth of the residual tumors and the postoperative function of the facial nerve because these have the potential to influence decision making. If the incidence of regrowth in incomplete excisions is acceptably low and a good postoperative facial nerve function is established, a sound policy would be to leave behind tumor in cases in which it is closely adherent to the facial nerve and other important neurovasculature. This could be especially important in elderly patients and patients with comorbid conditions.
Terminology of Incomplete Resections and Algorithm
A variety of terms have been used to describe incomplete resections of VSs and those commonly used are neartotal resection, subtotal resection, and partial resection. 21 There is considerable ambiguity among reports regarding the definitions of NTR and STR (Table 7) . While most authors describe NTR and STR as percentages of initial tumor volume as evaluated intraoperatively, others specifically calculate it as the diameter or volume of tumor detected on postoperative MRI. 15, 35 Both descriptions have drawbacks. The drawback of the first description is that the percentage remnant of total tumor volume is itself a relative indicator. For example, a 5% residual of a 2-cm tumor is less than a 5% residual of a 4-cm tumor. 18 A drawback in the second description is that not all tumors left behind in the NTR group are visualized by postoperative MRI, and minimal residual tumor can be missed or lost due to regression of the tumor itself. Also, in early postoperative MRI, leptomeningeal, perineural, dural, or nodular enhancement within the internal auditory canal mimicking the residual tumor can be frequently seen and can often be difficult to distinguish from the tumor remnants. 15, 35 When it comes to volumetric versus diametric measurements of tumor, while some authors have stressed that volumetric determination is a reliable measure of tumor size and minimizes the risk of error due to partial volume effects, 19, 35 other investigators have found no differences in growth results between measurements of tumor volume and tumor diameter. 11 Volumetric determination also requires expertise and an imaging technique that may not be available at all centers.
For comparability in reporting outcomes, a standard norm should be universally adopted that clearly differen- tiates between STR and NTR. 18 We are of the opinion that VS resections must be classified in a way that includes the surgeon's observation and the postoperative detection of tumor on MRI. The resections can be categorized as gross total resection (GTR), NTR, STR, and PR as shown in Table 1 .
Indications for NTR and STR
From the time when Dandy in 1925 advocated total excision of all VSs in the initial surgery there has been a shift in surgical practice, a willingness to leave a tumor remnant in situ if there was any concern that a more aggressive resection would cause trauma to the facial nerve and other neurovascular structures. 12 Most authors agree that the current indications for NTR and STR are 1) involvement of the facial nerve, the brainstem, or the vasculature of the cerebellopontine angle and brainstem; 2) unexpected bleeding during surgery; 3) older age; and 4) comorbidities. We have encountered a few other specific situations that required NTR or STR such as blindness in the eye on the side contralateral to tumor (where a special effort was made to preserve the ipsilateral facial nerve), intraoperative change in vital parameters, or cerebellar edema in large VSs. However, such cases were not included in the present series as they did not fit into the present inclusion criteria.
Extent of Resection and Regrowth
Although many factors have been reported to contribute to regrowth in patients with tumor remnants, including the extent of resection, 12,32 postoperative imaging findings, 7 and the proliferative activity of the tumor itself, 1, 5, 20 little is known about the clinicopathological characteristics of VSs that recur during long-term follow-up after incomplete resection. 15 In Table 7 we compare our results with other studies regarding the incidence of regrowth in incomplete VS resections. The reported incidence of regrowth in the subset of NTR ranged from 0% to 3.5% and in the subset of STR from 18.4% to 73.9%. In both groups our series represented the lowest rate of recurrences when compared with all other studies. It is evident from other studies and ours that the degree of resection correlates with recurrence rate. The study by Vakilian et al. 35 showed that patients who had tumor regrowth had mean postoperative tumor volumes that were significantly larger (p = 0.041) than those patients with stable residual tumors. All patients with residual tumor volumes in excess of 2.5 cm 3 exhibited further tumor growth. In their study, univariate analysis demonstrated that only postoperative tumor volume (p < 0.05) was significantly associated with growth. Sex, age, preoperative and postoperative planimetric dimensions, and preoperative volume had no significant association with tumor growth. In their study Carlson et al. 10 reported that among those patients with nodular enhancement on baseline postoperative MRI, a maximum linear diameter of at least 15 mm or a volume of at least 0.4 cm 3 was associated with an approximately 5-fold increased risk for future growth (p < 0.02).
Tumor Consistency and Regrowth
Cystic VSs are widely described as being more aggressive and having shorter symptomatic periods before presentation, poorer responses to radiosurgery, and worse outcomes from surgical intervention. 29 Factors that lead to unfavorable surgical outcomes include engulfment of and adherence to neurovascular structures, hypervascular solid portions of the tumor, and absence of an adequate subarachnoid dissection plane. Proliferative activities of cystic tumors are also reportedly higher than average. Although it is more likely that cystic tumors may only undergo incomplete excision, there is no evidence in the literature to indicate that cystic tumors are more prone to regrowth than solid VSs. In our study, 62 incomplete resections (55.86%) included cystic VSs. However, only 1 (1.6%) of them showed regrowth that was a cystic VS.
Other Factors Influencing Regrowth
There could be other factors influencing tumor regrowth. In general, tumor regrowth after surgery is influenced by the cellularity and vascularity of the tumor itself. 15 It has been shown that vascularization is derived from tumor angiogenesis when the VS is larger than 20 mm. 22 Another factor that may influence regrowth is the fact that VS growth is slower in elderly patients. 1, 26, 33 One research group studied the growth behavior of 50 untreated VSs in elderly patients and found measurable tumor growth (0.005-1.24 cm/year) in 50% of those cases and significant tumor growth (> 0.2 cm/year) in 20%. The authors stressed that conservative management should be continued in elderly patients with asymptomatic tumors. 26 In contrast, a recent study of patients with VSs managed conservatively demonstrated no significant association between tumor growth rate and age. 4 
Interval for Tumor Recurrence and Implications
It has been reported that after initial surgery, most residual tumors appear to have a quiescent period with no evidence of growth on follow-up imaging studies. 12 Previous studies have reported a mean interval between surgery and regrowth of 32-43 months with a range between 7.2 and 108 months. 8, 10, 12, 17 Our study is consistent with other studies with a mean interval between surgery and regrowth of 41 months (range 12-73 months). This implies that patients with incomplete resections must be subjected to follow-up MRI for a period of at least 7-10 years with a peak index of suspicion at around 3 years for regrowth. In incomplete resections, it is our policy to obtain a baseline MRI study at the 3rd postoperative month and repeat imaging every year for 7-10 years postoperatively or as indicated clinically.
Facial Nerve Outcome After Incomplete Excisions
The facial nerve outcome of various studies of incomplete VS excisions is compared in Table 8 . In NTR, good facial nerve outcomes (HB Grades I and II) have been reported to be between 51% and 84% and in STR, in the range of 55% and 100%. We have had good facial nerve outcomes in 47.4% of patients undergoing NTR and in 49.3% of the patients undergoing STR. The lower percentages of good facial nerve function postoperatively in our series could be attributed to the fact that, as in all our earlier reports, 6, 13, 30 we prefer to err on the side of the worse grade in cases in which the HB grades were between II and III. Table 7 also points to the fact that the tumors in our series were larger than those in all other series as measured by the mean tumor diameter, which could also be a factor affecting facial nerve outcome. In their study, Bloch et al. 9 proved that tumor size is one of the main predictors of facial nerve outcomes in VS. As the tumor grows, the facial nerve is under tension, which increases the likelihood of stretch injury and poor vascularization may explain the high rate of facial palsy seen in patients with large tumors. Falcioni et al. 13 pointed out that the results of the facial nerve for VSs larger than 3 cm were not satisfactory in a high percentage of their cases; in fact, in this group of patients, 20.6% had HB Grades IV-VI 1 year after surgery, even in cases in which there was anatomical preservation of the nerve.
Management Algorithm
Treatment options for residual tumor regrowth are wait-and-rescan, SRS, or revision surgery. The enlarged translabyrinthine approach in VS surgery has the advantages of a low rate of morbidity and a short hospital stay, and in our opinion this is the best approach for the removal of large VSs. 3, 31 Our policy for incomplete resections is to try to achieve NTR in as many cases as possible and proceed to an STR only in the remaining cases. All patients undergo follow-up for 7-10 years. In partial resections, we prefer to perform a staged surgery and achieve a GTR if possible or at least an NTR or STR. Based on this we propose the algorithm shown in Fig. 3 . The mean age of the patients who underwent NTR or STR in our series is 62 years. Eight patients (7.2%) were younger than 40 years, 29 (26.1%) were between 40 and 60 years, and 74 (66.67%) of the patients were older than 60 years of age. Of the 8 patients younger than 40 years, 6 had involvement of the brainstem or important vessels and 2 had involvement of the facial nerve. Seven patients (87.5%) underwent NTR and 1 (12.5%) underwent STR. This reflects our policy to try to achieve GTR in all young patients whenever possible and if not, at least an NTR. Our experience shows that GTR also can lead to recurrences in a very small percentage of cases. 2 The algorithm incorporates our management policy in such a scenario. In elderly patients, despite the fact that complete removal is the main target of the surgery, adoption of NTR or STR in selected cases can decrease neurovascular injury, improve postoperative facial nerve results, and reduce the duration of surgery. 27 In case of a regrowth following such a scenario, SRS or Gamma Knife surgery (GKS) is preferable.
Stereotactic radiosurgery is a useful tool in the management of residual tumors. There have been encouraging reports wherein large VSs have been managed by planned STR followed by SRS. 36 Preservation of facial nerve function is reportedly good following SRS. 36 Indications and protocols for SRS are still evolving, and more reports are likely to emerge in the future that will increase the role for SRS. However, a drawback is that of malignant transformation after SRS and although this has not been proven in a large study, this could lie between 1 in 1000 and 3 in 200,000 treated patients. 16, 24 We prefer to apply SRS in specific situations such as in elderly patients with residual tumors, patients with comorbid conditions, or in patients with slow-growing residual tumors after NTR or STR. A comparison between surgery and SRS for residual tumors is beyond the scope of this article. 
Conclusions
The decision to leave behind tumor attached to the facial nerve in an attempt to save the nerve can be justified if the following 2 factors can be proved: 1) that the incidence and the rate of tumor regrowth is acceptably low and 2) if there is a significant benefit in terms of postoperative facial nerve function preservation. Our report and a review of literature have shown that this is indeed the case and hence there is undoubtedly merit in the concept of NTR and STR for preservation of important neurovasulature, especially the facial nerve. On the basis of this we propose an algorithm for the management of patients with incomplete excisions of VSs. Patients with incomplete excisions must be subjected to follow-up MRI for a period of at least 7-10 years. Tumor regrowth is likely in solid tumors. When compared with STR, NTR through an enlarged translabyrinthine approach has shown to have a lower rate of regrowth of residual tumor, while having almost the same result in terms of facial nerve function.
